Golden
Catalyst Biosciences

Catalyst Biosciences

Catalyst Biosciences is a pharmaceutical company developing products to address hemophilia.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

December 3, 2008

Catalyst Biosciences raises a $40,000,000 series C round from Morgenthaler Ventures, HealthCare Ventures and Novartis Venture Fund.

February 9, 2006

Catalyst Biosciences raises a $30,000,000 series B round from Morgenthaler Ventures, HealthCare Ventures and Novartis Venture Fund.

People

Name
Role
LinkedIn

Brajesh Kumar

Employee



David L Sloane

Employee



Elena Kren

Employee



Jacob Esparza

Employee



Jeff Landau

Employee



Lianne Gong

Employee



Further reading

Title
Author
Link
Type
Date
+ Add new row

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row